Search

everythinglearnresearchcommunity

for

Search:↓

Biliary fibrosis is crucial in liver diseases and understanding it can help prevent and treat these conditions.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Euph E and Euri A from Euphorbia neriifolia help control inflammation and immune response in cells.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Improving mitochondrial health may help alleviate symptoms like chronic fatigue and depression.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Some moles can disappear naturally, maintenance therapy for Stage 1 mycosis fungoides may not be necessary, allergic skin reactions in children are rising, weekly methotrexate for psoriasis is more effective than daily, long-term finasteride use improves hair growth with few side effects, and petrolatum improves UV therapy for psoriasis.

Type I interferons play a key role in the development of various skin diseases.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Icariin can regulate macrophages and may help treat inflammation, cancer, bone disorders, and fibrotic diseases.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Tattoos may trigger autoimmune symptoms in some people.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

Blocking the CXCL12–CXCR4 axis may help treat hair loss in alopecia.

Vitamin D boosts a specific protein in skin cells linked to hair follicles.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Post-COVID-19 syndrome is complex, affects 5%-10% of people, and requires better research and global collaboration for treatment.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.